Sphera Funds Management Ltd. Intra Cellular Therapies, Inc. Call Options Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$17.61 - $31.86 $4.03 Million - $7.29 Million
-228,700 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$14.35 - $26.64 $3.28 Million - $6.09 Million
228,700 New
228,700 $5.87 Million
Q3 2019

Nov 14, 2019
SELL
$7.47 - $14.03 $2.24 Million - $4.21 Million
-300,000 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$10.9 - $14.09 $3.27 Million - $4.23 Million
300,000 New
300,000 $3.65 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.1M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.86B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email